Improved detection of sentinel lymph node metastases allows reliable intraoperative identification of patients with extended axillary lymph node involvement in early breast cancer

被引:3
作者
Cotarelo, Cristina L. [1 ,2 ]
Zschoeck-Manus, Annemarie [3 ]
Schmidt, Marcus [4 ]
Schad, Arno [3 ]
Brochhausen, Christoph [5 ]
Kirkpatrick, Charles James [3 ]
Thaler, Sonja [6 ]
机构
[1] Heinrich Heine Univ, Inst Pathol, Moorenstr 5, D-40225 Dusseldorf, Germany
[2] Univ Hosp Duesseldorf, Moorenstr 5, D-40225 Dusseldorf, Germany
[3] Johannes Gutenberg Univ Mainz, Inst Pathol, Univ Med Ctr, Mainz, Germany
[4] Johannes Gutenberg Univ Mainz, Dept Gynecol & Obstet, Univ Med Ctr, Mainz, Germany
[5] Univ Regensburg, Inst Pathol, Regensburg, Germany
[6] Heidelberg Univ, Med Fac Mannheim, European Ctr Angiosci ECAS, Mannheim, Germany
关键词
Sentinel lymph node; Metastases; Touch imprint cytology; Frozen section; INTERNATIONAL EXPERT CONSENSUS; TOUCH IMPRINT CYTOLOGY; CLINICAL-PRACTICE; AMERICAN-SOCIETY; FROZEN-SECTION; PROGNOSTIC-FACTORS; PRIMARY THERAPY; CARCINOMA; BIOPSY; DISSECTION;
D O I
10.1007/s10585-020-10065-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background An improved procedure that allows accurate detection of negative sentinel lymph node (SLN) and of SLN macrometastases during surgery would be highly desirable in order to protect patients from further surgery and to avoid unnecessary costs. We evaluated the accuracy of an intraoperative procedure that combines touch imprint cytology (TIC) and subsequent frozen section (FS) analysis. 2276 SLNs from 1072 patients with clinical node-negative early breast cancer were evaluated during surgery using TIC. Only cytologically-positive SLN were subsequently analysed with a single FS, preserving cytologically-negative SLN for the final postoperative histological diagnosis. Sensitivity, specificity and the accuracy of this approach were analysed by comparing the results from intra- and postoperative SLN and axillary node evaluation. This intraoperative method displayed 100% specificity for SLN metastases and was significantly more sensitive for prognostically relevant macrometastases (85%) than for micrometastases (10%). Sensitivity was highest for patients with two or more positive LNs (96%) than for those with only one (72%). 98% of the patients with final pN2a-pN3a were already identified during surgery. Patients who received primary axillary lymph node dissection had significantly more frequent metastases in further LNs (44.6%). Sensitivity was highest for patients with luminal-B, HER2+ and triple negative breast cancer and for any subtype if Ki-67 > 40%. TIC and subsequent FS of cytologically-positive SLNs is highly reliable for detection of SLN macrometastases, and allows accurate identification of patients with a high risk of extended axillary involvement during surgery, as well as accurate histological diagnosis of negative SLN.
引用
收藏
页码:61 / 72
页数:12
相关论文
共 36 条
  • [1] AGRESTI A., 1992, Stat Sci, V7, P131, DOI [10.1214/ss/1177011454, DOI 10.1214/SS/1177011454]
  • [2] Application of ACOSOG Z0011 Criteria Reduces Perioperative Costs
    Camp, Melissa S.
    Greenup, Rachel A.
    Taghian, Alphonse
    Coopey, Suzanne B.
    Specht, Michelle
    Gadd, Michele
    Hughes, Kevin
    Smith, Barbara L.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (03) : 836 - 841
  • [3] Tailoring therapies-improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
    Coates, A. S.
    Winer, E. P.
    Goldhirsch, A.
    Gelber, R. D.
    Gnant, M.
    Piccart-Gebhart, M.
    Thuerlimann, B.
    Senn, H. -J.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 (08) : 1533 - 1546
  • [4] A model for determining the optimum histology of sentinel lymph nodes in breast cancer
    Cserni, G
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2004, 57 (05) : 467 - 471
  • [5] De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
    Curigliano, G.
    Burstein, H. J.
    Winer, E. P.
    Gnant, M.
    Dubsky, P.
    Loibl, S.
    Colleoni, M.
    Regan, M. M.
    Piccart-Gebhart, M.
    Senn, H. -J.
    Thurlimann, B.
    Andre, F.
    Baselga, J.
    Bergh, J.
    Bonnefoi, H.
    Brucker, S. Y.
    Cardoso, F.
    Carey, L.
    Ciruelos, E.
    Cuzick, J.
    Denkert, C.
    Di Leo, A.
    Ejlertsen, B.
    Francis, P.
    Galimberti, V.
    Garber, J.
    Gulluoglu, B.
    Goodwin, P.
    Harbeck, N.
    Hayes, D. F.
    Huang, C. -S.
    Huober, J.
    Khaled, H.
    Jassem, J.
    Jiang, Z.
    Karlsson, P.
    Morrow, M.
    Orecchia, R.
    Osborne, K. C.
    Pagani, O.
    Partridge, A. H.
    Pritchard, K.
    Ro, J.
    Rutgers, E. J. T.
    Sedlmayer, F.
    Semiglazov, V.
    Shao, Z.
    Smith, I.
    Toi, M.
    Tutt, A.
    [J]. ANNALS OF ONCOLOGY, 2017, 28 (08) : 1700 - 1712
  • [6] Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial
    Donker, Mila
    van Tienhoven, Geertjan
    Straver, Marieke E.
    Meijnen, Philip
    van de Velde, Cornelis J. H.
    Mansel, Robert E.
    Cataliotti, Luigi
    Westenberg, A. Helen
    Klinkenbijl, Jean H. G.
    Orzalesi, Lorenzo
    Bouma, Willem H.
    van der Mijle, Huub C. J.
    Nieuwenhuijzen, Grard A. P.
    Veltkamp, Sanne C.
    Slaets, Leen
    Duez, Nicole J.
    de Graaf, Peter W.
    van Dalen, Thijs
    Marinelli, Andreas
    Rijna, Herman
    Snoj, Marko
    Bundred, Nigel J.
    Merkus, Jos W. S.
    Belkacemi, Yazid
    Petignat, Patrick
    Schinagl, Dominic A. X.
    Coens, Corneel
    Messina, Carlo G. M.
    Bogaerts, Jan
    Rutgers, Emiel J. T.
    [J]. LANCET ONCOLOGY, 2014, 15 (12) : 1303 - 1310
  • [7] PATHOLOGICAL PROGNOSTIC FACTORS IN BREAST-CANCER .1. THE VALUE OF HISTOLOGICAL GRADE IN BREAST-CANCER - EXPERIENCE FROM A LARGE STUDY WITH LONG-TERM FOLLOW-UP
    ELSTON, CW
    ELLIS, IO
    [J]. HISTOPATHOLOGY, 1991, 19 (05) : 403 - 410
  • [8] Fitzgibbons PL, 2000, ARCH PATHOL LAB MED, V124, P966
  • [9] Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial
    Giuliano, Armando E.
    Ballman, Karla
    McCall, Linda
    Beitsch, Peter
    Whitworth, Pat W.
    Blumencranz, Peter
    Leitch, A. Marilyn
    Saha, Sukamal
    Morrow, Monica
    Hunt, Kelly K.
    [J]. ANNALS OF SURGERY, 2016, 264 (03) : 413 - 420
  • [10] Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis A Randomized Clinical Trial
    Giuliano, Armando E.
    Hunt, Kelly K.
    Ballman, Karla V.
    Beitsch, Peter D.
    Whitworth, Pat W.
    Blumencranz, Peter W.
    Leitch, A. Marilyn
    Saha, Sukamal
    McCall, Linda M.
    Morrow, Monica
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (06): : 569 - 575